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ABSTRACT
Introduction and aim Exposure to some insecticides 
may cause airway obstruction, but existing evidence 
is limited by cross- sectional designs and inadequate 
confounder control. We investigated the relation between 
organophosphate and carbamate insecticides and 
pulmonary function in a prospective study accounting for 
important confounders.
Methods In a cohort of 364 smallholder farmers 
in Uganda (69% women), participants underwent 
pre- bronchodilator spirometry at baseline (September/
October 2018) and at two follow- up visits (November/
December 2018 and January/February 2019). Exposure 
to carbamate and organophosphate insecticides was 
assessed using haemoglobin- adjusted erythrocyte 
acetylcholinesterase (AChE/Hb). Less than 3% of 
participants were lost to follow- up. We calculated 
Z- scores for FEV1, FVC and FEV1/FVC using the Global 
Lung Function Initiative equations. Data were analysed 
in linear mixed and fixed effect models accounting for 
family relationships and repeated measures of exposure 
and outcome.
Results Low AChE/Hb was significantly associated 
with low FEV1 Z- score in both unadjusted and adjusted 
analyses. Compared with individuals with AChE/Hb 
25.90 U/g (50th percentile, reference), those with lower 
AChE/Hb 24.50 U/g (35th percentile) had mean FEV1 
Z- score 0.045 (0.003 to 0.087) lower, and persons with 
higher AChE/Hb 27.30 U/g (65th percentile) had a mean 
FEV1 Z- score 0.043 (−0.002 to 0.087) higher compared 
with the reference. Similar, but numerically smaller and 
statistically non- significant effects were seen for Z- scores 
of FVC and FEV1/FVC.
Conclusion Exposure to organophosphate and 
carbamate insecticides may lead to lung function decline. 
Our results add to the growing evidence of health 
effects in relation to exposure to organophosphate and 
carbamate insecticides, underlining the importance of 
minimising exposure.
INTRODUCTION
Asthma and chronic obstructive pulmonary disease 
are major public health challenges, with estimated 
global prevalence of 273 million and 299 million 
people, respectively.1 Some risk factors for these 
diseases are well- known, including tobacco 
smoking,2 3 genetic susceptibility and air pollu-
tion.2 4 It has also been suggested that exposure to 
some classes of pesticides can lead to lung function 
impairment, both in the general population5 6 and 
among occupationally exposed workers.7 Acute 
poisoning with acetylcholine- inhibiting insecticides 
(organophosphates and carbamates) can lead to 
respiratory failure,8 partly due to bronchoconstric-
tion and increased mucus production in the airways.8 
Exposure to organophosphates and carbamates at 
levels too low to cause acute intoxication might 
lead to airway obstruction. A recent systematic 
review and meta- analysis on pesticide exposure and 
lung function indicated that exposure to cholines-
terase (ChE) inhibiting pesticides may reduce FEV1/
FVC.9 However, the confidence in the findings was 
limited, as most studies were cross- sectional, had 
inadequate confounder control and did not investi-
gate exposure–response relationships.9
Smallholder farmers in low- and middle- income 
countries can be heavily exposed to pesticides 
due to a lack of training, unsafe pesticide applica-
tion practices and limited use of personal protec-
tive equipment.10–13 If pesticide exposure impairs 
pulmonary function, such farmers may therefore be 
Key messages
What is the key question?
 ► Is exposure to cholinesterase- inhibiting 
insecticides associated with pulmonary function 
impairment?
What is the bottom line?
 ► Low erythrocyte acetylcholinesterase was 
associated with low FEV1 among farmers, 
suggesting that subchronic exposure to 
cholinesterase inhibiting insecticides leads to 
impairment of lung function.
Why read on?
 ► We improve on previous studies by using 
repeated measurements of both exposure 
and lung function and adjusting for important 
confounders, thereby reducing the risk of bias 
in our analyses.
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some of the most affected persons, though few previous studies 
have focussed specifically on this group. Hence, the objective 
of this study was to investigate whether subchronic exposure to 
organophosphate and carbamate insecticides was associated with 
impaired lung function among smallholder farmers in Uganda, 




The study was conducted as part of the ‘Pesticide Exposure, 
Asthma and Diabetes in Uganda’ (PEXADU) project,14 a short- 
term cohort study among members of two organisations of small-
holder farmers from the Wakiso District in central Uganda—one 
for conventional farmers, and one for farmers working towards 
organic certification. We recruited participants from these two 
organisations to minimise confounding from sociodemographic 
variables while maximising insecticide exposure contrast. Partic-
ipants were examined at baseline in September/October 2018 
(phase 1) and at two follow- up visits in November/December 
2018 (phase 2) and January/February 2019 (phase 3). The main 
insecticide application season in the study area is October/
November (personal communication, Aggrey Atuhaire, Uganda 
National Association of Community and Occupational Health), 
and we selected the timing of the three rounds of examinations 
to also maximise contrast in insecticide exposure within the 
participants.
Study population
We attended the weekly meetings among small groups in each 
farmers’ organisation and invited all members 18 years or older 
to participate. Pregnant women were excluded. We compiled a 
list of 532 persons potentially eligible for participation, and used 
a pseudo- random number generator to randomise the sequence 
of persons on the list. Potential participants were invited in 
sequence by telephone. If a person could not be reached by tele-
phone, or was unable to participate, we excluded that person 
and called the next person on the list. At baseline, 380 out of 532 
individuals came to the examination centre, and after exclusion 
of ineligible persons, we included 364 participants. We re- exam-
ined 356 and 354 subjects in phase 2 and phase 3, respectively 
(see figure 1).
Outcome assessment
Pulmonary function was quantified by pre- bronchodilator 
spirometry using a MicroDL spirometer and Spida 5 PC soft-
ware (Micro Medical, Rochester, Kent, England). Exclusion 
criteria were myocardial infarction in the last 3 months, angina 
pectoris, haemoptysis, any surgery in the last 3 months, aortic 
aneurysm, history of pulmonary embolism, active tuberculosis, 
other current respiratory infection and severe hypertension 
(systolic >200 mm Hg or diastolic >120 mm Hg). If standard 
American Thoracic Society (ATS) criteria15 for quality of spirom-
etry were not fulfilled after five blows, four additional attempts 
were provided. After the examination, quality and repeatability 
of all manoeuvres were assessed by a medical doctor with expe-
rience in pulmonary function testing, according to modified ATS 
criteria (online supplemental appendix 1). Reliable spirometry 
results were available for 290, 285 and 263 persons in phase 1, 
phase 2 and phase 3, respectively (see figure 2).
The primary outcomes were Z- scores for forced expiratory 
volume in the first second (FEV1), forced vital capacity (FVC) 
and FEV1/FVC, calculated using the Global Lung Function Initia-
tive (GLI-2012) equations,16 with ‘African- American’ ethnicity 
Figure 1 Flowchart of participant recruitment.
2 Hansen MRH, et al. Thorax 2021;0:1–10. doi:10.1136/thoraxjnl-2020-214609
 on F











as the reference, while absolute values of FEV1, FVC and FEV1/
FVC were secondary outcomes. Peak expiratory flow (PEF), 
instantaneous forced expiratory flow after exhalation of 25%, 
50% and 75% of the FVC (FEF25, FEF50 and FEF75), mean forced 
expiratory flow between 25% and 75% of the FVC (FEF25-75) 
and FEF25-75 Z- score were also secondary outcomes.
Exposure assessment
To quantify exposure to organophosphate and carbamate insec-
ticides, we used capillary blood erythrocyte acetylcholinesterase 
(AChE) analysed using a point- of- care device (Test- mate ChE 
Cholinesterase Test System Model 400, EQM Research Inc, 
Cincinnati, Ohio, USA). The analysis was performed immedi-
ately after blood sampling, and according to the manufactur-
er’s instructions.17 The primary toxicodynamic mode of action 
of organophosphate and carbamate insecticides is inhibition 
of nervous system acetylcholinesterase.18 The enzyme isoform 
in erythrocytes (AChE) is readily available for sampling, and 
can be measured as an expression of exposure in the short 
to medium term.19 Our primary exposure metric was AChE 
activity normalised by haemoglobin (Hb) concentration: AChE/
Hb (U/g). Results from the Test- Mate system were recorded on 
paper and later double- entered using the Open Data Kit (ODK) 
Collect application.20
Confounder selection and assessment
Confounders were defined a priori using Directed Acyclic 
Graphs21 and the DAGitty software.22 The basic set of 
confounders included age, sex, cumulated lifetime tobacco 
smoking and cumulated lifetime hours of cooking as a proxy 
for exposure to biofuel smoke. The extended set of confounders 
also included body mass index and years of full- time education 
as a proxy for socioeconomic status. For analyses of absolute 
spirometric indices, all analyses included sex, age and height 
as covariates. Tobacco smoking was quantified as pack- years. 
Biofuel smoke exposure was expressed as ‘cooking years’, 
defined as the number of years with an average of 2.5 hours 
of cooking per day. We did not adjust analyses for the specific 
spirometer used during testing, as calibration check data showed 
that differences between spirometers were minor and did not 
explain the observed temporal trends in spirometric results.23
Height and weight was measured in a standardised manner24 
using a stadiometer (SM- SZ-300, Sumbow Medical Instruments 
Co Ltd, Ningbo, China) and medical scale (seca robusta 813, 
seca GmbH & Co, Hamburg, Germany), respectively. Anthropo-
metric data was recorded directly in ODK Collect.20
Subjective covariate information was collected in a struc-
tured, questionnaire- based interview. Questions on demo-
graphic data and tobacco smoking derived from the WHO 
Figure 2 Flowchart describing numbers of participants who performed spirometry.
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STEPs questionnaire,25 while questions on exposure to biomass 
fuel smoke were adapted from the World Health Survey26 ques-
tionnaire. Finally, questions related to pesticide exposure were 
adapted from an existing questionnaire designed for use among 
smallholder farmers in low- and middle- income countries.13 27 We 
modified the existing pesticide questionnaire to make it simpler 
and faster to administer, while still collecting relatively detailed 
exposure information on, for example, duration and intensity 
of pesticide usage, and which specific pesticides were used. The 
interview was conducted in English or Luganda; the Luganda 
version of the questionnaire was back- translated to English 
before use. Interviewers entered answers directly into a database 
using ODK Collect.20
Statistical analyses
Data were managed using Python 3 (Python Software Founda-
tion, https://www. python. org/) and Stata 15 (StataCorp, College 
Station, Texas, USA), and analysed using Stata 15. The analysis 
plan was specified a priori and published online.21 For an over-
view of all analyses performed (including sensitivity analyses), 
and any deviations from the protocol, see online supplemental 
appendix 2.
All outcome variables were analysed on a continuous scale. To 
account for family relationships and repeated measurements of 
both exposure, outcome and covariates, data were analysed in 
a linear mixed effect model with random effects for family and 
participant, and fixed effects for the exposure and confounder 
variables. The regression coefficient for the exposure variable 
was allowed to vary between participants. A ‘family’ was defined 
as a group of participants where all members were genetically 
related to at least one other member of the group. The model 
can be described thus:




+ α+ τ + ε 
y is the outcome.  βb  is the regression coefficient for the effect 
of the exposure variable b on the outcome;  βb  is normally 
distributed in the study population, and each person has his/her 
own level of  βb  . The regression coefficient for the effect of the 
ith confounder ci is called  βc,i  and all members of the population 
have the same  βc,i  . Random effects for family and participant are 
called α and τ, respectively. ε is an error term.
Apart from sex, all independent variables were continuous 
and were generally modelled using restricted cubic splines with 
four knots to take into account non- linear exposure–response 
relationships. However, tobacco smoking was modelled under 
the assumption of linearity, as the number of smokers was too 
low to use splines (table 1). We used the xblc28 Stata package to 
plot results for spline variables.
Analyses only included participants with information on 
all covariates from at least one project phase. The number of 
observations in each model is available in online supplemental 
appendix 2. Due to a negligible loss to follow- up (see figure 1), 
we did not account for it statistically.
To remove the effect of unknown time- invariant confounders, 
we performed secondary fixed effect analyses focussing on the 
change in variables within each person between project phases. 





+ α+ ε 
 ∆y is the change in the outcome between two project phases. 
 ∆xi  is the change in the ith independent variable xi, and  βx,i  is the 
regression coefficient for the fixed effect of Δxi on Δy. All partic-
ipants have the same  βx,i  . α is a random effect for family, and ε 
is an error term. In our main fixed effect model, we compared 
phases 1+3. Sensitivity analyses compared phases 1+2 and 2+3, 
respectively.
RESULTS
Demographics of the study population are provided in table 1, 
both overall and stratified by AChE/Hb below or above the 
median at baseline. Two- thirds of participants were women, 
and most were middle- aged (median age 46.6 years). Few were 
ever- smokers, and the number of pack- years for ever- smokers 
was low. The vast majority of the participants used biomass fuels 
for cooking. Individuals above and below the median AChE/Hb 
were similar in terms of all included demographics, except for 
sex, where men had higher AChE/Hb than women. Self- reported 
use of pesticides, including cholinesterase- inhibiting insecticides, 
was similar in the two strata of AChE/Hb.
The mean pulmonary function (defined primarily by 
Z- scores of FEV1, FVC and FEV1/FVC) decreased across 
project phases, and so did AChE/Hb, table 2. The range of 
observed values showed considerable overlap between phases, 
and the changes in the means were numerically small, but most 
were statistically significant. Analyses of variance for both 
outcome and exposure variables are provided in online supple-
mental appendix 3. Most of the variance was between persons 
and between families, with less variation within persons. The 
ratio of within- person variance to the sum of between- person 
and between- family variance was 0.12 for FEV1 Z- score, 0.15 
for FVC Z- score, 0.43 for FEV1/FVC Z- score and 0.22 for 
AChE/Hb.
In our main analysis, FEV1 Z- score was significantly lower 
among individuals with low AChE/Hb, compared with persons 
with higher AChE/Hb, both in unadjusted analyses and adjusted 
analyses including the basic and extended sets of confounders 
(figure 3 and table 3). FVC Z- score and FEV1/FVC Z- score 
showed similar patterns as FEV1 Z- score, but differences were 
numerically smaller and statistically non- significant.
Analyses of absolute lung function measures generally 
confirmed the results for Z- scores, but were only statistically 
significant in unadjusted analyses for FEV1 (table 3 and online 
supplemental appendix 2). Analyses of the remaining secondary 
outcomes (such as PEF and FEF25) were less consistent (online 
supplemental appendix 2).
A number of preplanned sensitivity analyses conducted to 
check the robustness of the main findings generally gave similar 
results as the main analyses (online supplemental appendix 
2). However, in an adjusted post- hoc sensitivity analysis that 
included project phase as a categorical variable, no clear rela-
tionships were seen between AChE/Hb and spirometry Z- scores 
(see online supplemental appendix 2), probably due to the asso-
ciation between phase and exposure seen in table 2. In post- hoc 
analyses stratified by sex, associations between AChE/Hb and 
spirometry Z- scores were only evident for women (online 
supplemental appendix 2).
In the fixed effect model, we did not demonstrate any clear 
association between change in AChE/Hb between phase 1 
and phase 3, and the change in Z- scores of FEV1 and FVC, 
figure 4. We did see a statistically non- significant association 
between decreases in AChE/Hb between phases (corresponding 
to increased exposure) and decreases in FEV1/FVC Z- score, 
but this result should be interpreted with caution due to the 
unclear pattern for Z- scores of FEV1 and FVC. Sensitivity anal-
yses comparing phase 1/2 and phase 2/3 provided inconsistent 
results, online supplemental appendix 2.
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In our analyses, low AChE/Hb (indicating high exposure to 
organophosphate and carbamate insecticides) was associated 
with low values of most spirometric indices. The relationship was 
numerically largest and statistically significant for FEV1 Z- score, 
but similar trends were seen for FVC Z- score and FEV1/FVC 
Z- score. This indicates that exposure to organophosphate and 
carbamate insecticides might impair pulmonary function. Our 
confidence in the findings are somewhat tempered by the lack 
of clear exposure- response patterns in the fixed effect model, 
but the latter model may have been statistically underpowered 
due to a lower- than expected within- person exposure variability.
Table 1 Demographics for the study population at baseline
All participants AChE/Hb <26.3 U/g AChE/Hb ≥26.3 U/g
Total, n 364 181 183
Sex
  Female, n (%) 250 (68.7) 132 (72.9) 118 (64.5)
  Male, n (%) 114 (31.3) 49 (27.1) 65 (35.5)
Age, years 46.6 (36.7 to 56.5) 46.8 (37.0 to 56.5) 46.5 (36.6 to 56.5)
Years of full- time education 7.0 (5.0 to 11.0) 7.0 (5.0 to 10.0) 7.0 (5.0 to 11.0)
Ethnicity
  Baganda, n (%) 283 (77.7) 137 (75.7) 146 (79.8)
  Banyarwanda, n (%) 20 (5.5) 15 (8.3) 5 (2.7)
  Banyankore, n (%) 11 (3.0) 5 (2.8) 6 (3.3)
  Other, n (%) 50 (13.7) 24 (13.3) 26 (14.2)
Ever smoked tobacco?
  Yes, n (%) 42 (11.5) 17 (9.4) 25 (13.7)
  No, n (%) 322 (88.5) 164 (90.6) 158 (86.3)
Current smoker?
  Yes, n (%) 15 (4.1) 4 (2.2) 11 (6.0)
  No, n (%) 349 (95.9) 177 (97.8) 172 (94.0)
Pack- years (ever- smokers only) 2.1 (0.9 to 6.8) 4.0 (1.2 to 8.4) 1.8 (0.8 to 6.2)
Grams of tobacco per day for current smokers 1.1 (0.0 to 4.0) 1.9 (0.4 to 6.0) 1.1 (0.0 to 4.0)
Cooking fuel type in household
  Charcoal, n (%) 61 (16.8) 37 (20.4) 24 (13.1)
  Wood, n (%) 298 (81.9) 142 (78.5) 156 (85.2)
  No food cooked in household, n (%) 1 (0.3) 0 (0.0) 1 (0.5)
  Other, n (%) 4 (1.1) 2 (1.1) 2 (1.1)
Number of hours of cooking in the last week 8.0 (0.3 to 17.8) 8.0 (0.5 to 16.7) 8.0 (0.0 to 20.0)
Cumulated lifetime cooking (‘cooking years’) 16.7 (0.9 to 44.9) 14.9 (1.2 to 44.7) 17.5 (0.0 to 45.2)
BMI, kg/m2 23.3 (21.1 to 26.8) 23.2 (21.1 to 26.9) 23.3 (21.5 to 26.5)
Mean height across all phases, cm 158.9 (154.1 to 164.3) 158.5 (152.7 to 163.2) 159.5 (155.0 to 164.7)
Ever mixed or applied pesticides?*
  Yes, n (%) 283 (77.8) 140 (77.3) 143 (78.1)
  No, n (%) 81 (22.3) 41 (22.7) 40 (21.9)
Cholinesterase inhibitor insecticides among three most used pesticides, or used 
in the last week?†
  Yes, n (%) 133 (47.0) 64 (45.7) 69 (48.3)
  No, n (%) 114 (40.3) 53 (37.9) 61 (42.7)
  Unknown, n (%) 36 (12.7) 23 (16.4) 13 (9.1)
Cholinesterase inhibitor insecticides used in the last week?†
  Yes, n (%) 22 (7.8) 9 (6.4) 13 (9.1)
  No, n (%) 246 (86.9) 120 (85.7) 126 (88.1)
  Unknown, n (%) 15 (5.3) 11 (7.9) 4 (2.8)
Categorical variables are n (%). Continuous variables are median (IQR). AChE/Hb dichotomised by 26.3 U/g, the median AChE/Hb at baseline. One ‘cooking year’ is defined as 
cooking for 2.5 hours per day for 365.24 days.
*Includes both occupational and domestic use of pesticides.
†Data only presented for subjects who have ever mixed or applied pesticides.
AChE/Hb, erythrocyte acetylcholinesterase normalised by haemoglobin concentration; BMI, body mass index.
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Exposure to cholinesterase inhibitor insecticides is the most 
obvious explanation for depression of AChE/Hb in this popula-
tion of smallholder farmers. However, we did not see any clear 
differences in self- reported use of insecticides between persons 
with AChE/Hb below or above the median at baseline (table 2). 
The farmers might mainly be exposed in ways on which we do 
not have information, such as re- entry exposure during work in 
previously sprayed fields, or through diet. Of note, insecticide 
exposure is not the only factor that can influence AChE/Hb.29 
Our results could therefore be confounded, but the problem is 
likely limited, as demographics between the low and high AChE/
Hb groups at baseline were generally similar, and results from 
unadjusted and adjusted analyses of Z- scores for FEV1, FVC and 
FEV1/FVC were nearly identical. Because of the lack of asso-
ciation between subjective exposure to cholinesterase inhibitor 
insecticides and AChE/Hb, we did not adjust our analyses for 
use of other pesticides (such as pyrethroid insecticides, glypho-
sate and dithiocarbamate fungicides), for which we currently 
only have subjective exposure information and no biomarkers. 
Depressed AChE/Hb could therefore be a proxy for exposure to 
other agrochemicals.
Our findings support previous mainly cross- sectional studies 
showing associations between decreased pulmonary function 
and exposure to cholinesterase- inhibiting insecticides, expressed 
as either urinary metabolites of organophosphates,5 6 30 or 
depressed cholinesterase activity.31–35 Most previous studies were 
conducted among occupationally exposed workers and farmers, 
the majority of whom were men.30–35 Two studies showed asso-
ciations in general populations with more balanced gender 
distributions.5 6 Thus, our study differs somewhat from previous 
studies, as our study population was occupationally exposed and 
most participants were women, and caution is warranted before 
directly comparing numerical estimates from the current and 
previous studies.
A link between exposure and lung function impairment is 
biologically plausible, as acute intoxication with cholinesterase 
inhibitor insecticides leads to bronchoconstriction.8 Support is 
also provided by a double- blind, randomised, placebo- controlled 







FEV1 (L) 2.36 (1.94 to 2.88) 2.33 (1.92 to 2.78) 2.28 (1.91 to 2.81) −0.04 (−0.05 to −0.03)
n 290 285 263   
FVC (L) 2.82 (2.36 to 3.47) 2.83 (2.33 to 3.41) 2.77 (2.37 to 3.41) −0.03 (−0.04 to −0.01)
n 288 285 263   
FEV1/FVC 0.83 (0.80 to 0.87) 0.83 (0.79 to 0.87) 0.83 (0.79 to 0.87) −0.01 (−0.01 to −0.00)
n 288 285 263   
PEF (L/s) 6.01 (5.06 to 7.40) 6.15 (5.21 to 7.41) 5.93 (5.22 to 7.31) 0.01 (−0.04 to 0.07)
n 290 285 263   
FEF25 (L/s) 5.08 (4.04 to 5.99) 4.96 (3.97 to 5.90) 4.94 (3.89 to 5.90) −0.05 (−0.11 to 0.01)
n 290 285 263   
FEF50 (L/s) 3.18 (2.30 to 3.73) 2.94 (2.19 to 3.71) 2.94 (2.16 to 3.72) −0.09 (−0.13 to −0.06)
n 290 285 263   
FEF75 (L/s) 0.95 (0.70 to 1.33) 0.93 (0.66 to 1.25) 0.90 (0.64 to 1.27) −0.04 (−0.06 to −0.02)
n 290 285 263   
FEF25-75 (L/s) 2.47 (1.82 to 3.13) 2.35 (1.73 to 3.05) 2.35 (1.67 to 3.02) −0.07 (−0.10 to −0.04)
n 290 285 263   
FEV1 Z- score −0.155 (−0.750 to 0.405) −0.220 (−0.802 to 0.356) −0.315 (−0.893 to 0.229) −0.10 (−0.13 to −0.07)
n 290 285 263   
FVC Z- score −0.257 (−0.850 to 0.387) −0.307 (−0.798 to 0.297) −0.342 (−0.933 to 0.196) −0.06 (−0.09 to −0.03)
n 288 285 263   
FEV1/FVC Z- score 0.127 (−0.402 to 0.793) 0.142 (−0.511 to 0.757) 0.119 (−0.491 to 0.744) −0.08 (−0.13 to −0.03)
n 288 285 263   
FEF25-75 Z- score −0.234 (−0.780 to 0.419) −0.227 (−0.777 to 0.294) −0.306 (−0.882 to 0.341) −0.07 (−0.11 to −0.04)
n 290 285 263   
AChE (U/mL) 3.10 (2.74 to 3.48) 2.98 (2.63 to 3.31) 2.88 (2.54 to 3.22) −0.12 (−0.14 to −0.10)
n 364 353 354   
Hb (g/dL) 11.80 (11.10 to 12.70) 11.50 (10.60 to 12.20) 11.70 (10.80 to 12.40) −0.13 (−0.18 to −0.07)
n 364 353 354   
AChE/Hb (U/g) 26.30 (23.90 to 28.10) 26.20 (23.70 to 28.40) 24.70 (22.30 to 27.20) −0.74 (−0.85 to −0.63)
n 364 353 354   
All variables are presented as median (IQR). Z- scores and FEV1/FVC are unitless. Δ/phase denotes the mean change in the variable when phase increases by 1. CIs for Δ/phase 
was calculated in a mixed effect model with random effects for family and person, and fixed effect for phase.
AChE/Hb, erythrocyte acetylcholinesterase normalised by haemoglobin concentration.
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Figure 3 Results from random coefficient model of pulmonary function versus AChE/Hb. Solid line shows lung function parameter relative to 
value at the median AChE/Hb. Dashed lines show 95% CI. Spline knot location shown by black dots. Histograms show the distribution of AChE/Hb 
values for observations in the model. Basic covariate set=age, sex, pack- years of smoking, cumulated lifetime hours of cooking. Extended covariate 
set=basic set+BMI, years of full- time education. AChE/Hb, erythrocyte acetylcholinesterase normalised by haemoglobin concentration.
Table 3 Summary table of results from random coefficient model
AChE/Hb U/g 19.79 24.50 25.90 27.30 32.61
Percentile 5 35 50 65 95
FEV1 Z- score Unadjusted −0.153 (−0.289 to −0.016) −0.050 (−0.091 to −0.010) 0 (ref.) 0.048 (0.005 to 0.091) 0.126 (0.007 to 0.244)
Adjusted, basic −0.155 (−0.296 to −0.014) −0.045 (−0.087 to −0.003) 0 (ref.) 0.043 (−0.002 to 0.087) 0.116 (−0.004 to 0.236)
Adjusted, extended −0.153 (−0.293 to −0.012) −0.043 (−0.085 to −0.001) 0 (ref.) 0.040 (−0.005 to 0.085) 0.108 (−0.013 to 0.228)
FVC Z- score Unadjusted −0.041 (−0.193 to 0.111) −0.019 (−0.065 to 0.026) 0 (ref.) 0.019 (−0.029 to 0.067) 0.036 (−0.096 to 0.169)
Adjusted, basic −0.038 (−0.192 to 0.116) −0.017 (−0.063 to 0.029) 0 (ref.) 0.017 (−0.032 to 0.066) 0.034 (−0.098 to 0.167)
Adjusted, extended −0.036 (−0.189 to 0.116) −0.015 (−0.061 to 0.031) 0 (ref.) 0.014 (−0.034 to 0.063) 0.024 (−0.107 to 0.156)
FEV1/FVC Z- score Unadjusted −0.063 (−0.261 to 0.135) −0.030 (−0.091 to 0.030) 0 (ref.) 0.033 (−0.032 to 0.098) 0.104 (−0.074 to 0.282)
Adjusted, basic −0.066 (−0.264 to 0.132) −0.020 (−0.080 to 0.040) 0 (ref.) 0.020 (−0.044 to 0.085) 0.075 (−0.100 to 0.249)
Adjusted, extended −0.058 (−0.254 to 0.139) −0.018 (−0.079 to 0.042) 0 (ref.) 0.020 (−0.045 to 0.084) 0.079 (−0.095 to 0.253)
FEV1 Unadjusted −0.041 (−0.091 to 0.010) −0.017 (−0.032 to −0.002) 0 (ref.) 0.017 (0.001 to 0.033) 0.039 (−0.005 to 0.083)
Adjusted, basic −0.042 (−0.094 to 0.011) −0.016 (−0.031 to 0.000) 0 (ref.) 0.015 (−0.001 to 0.032) 0.037 (−0.008 to 0.082)
Adjusted, extended −0.041 (−0.094 to 0.011) −0.015 (−0.031 to 0.001) 0 (ref.) 0.014 (−0.002 to 0.031) 0.034 (−0.011 to 0.079)
FVC Unadjusted −0.002 (−0.067 to 0.063) −0.004 (−0.024 to 0.015) 0 (ref.) 0.005 (−0.016 to 0.025) 0.006 (−0.050 to 0.063)
Adjusted, basic −0.003 (−0.070 to 0.064) −0.004 (−0.024 to 0.016) 0 (ref.) 0.004 (−0.017 to 0.026) 0.006 (−0.052 to 0.063)
Adjusted, extended −0.003 (−0.070 to 0.063) −0.003 (−0.023 to 0.017) 0 (ref.) 0.003 (−0.018 to 0.024) 0.002 (−0.055 to 0.059)
FEV1/FVC Unadjusted −0.007 (−0.019 to 0.005) −0.002 (−0.006 to 0.002) 0 (ref.) 0.002 (−0.002 to 0.006) 0.006 (−0.005 to 0.017)
Adjusted, basic −0.007 (−0.019 to 0.006) −0.002 (−0.005 to 0.002) 0 (ref.) 0.001 (−0.003 to 0.006) 0.005 (−0.006 to 0.016)
Adjusted, extended −0.006 (−0.019 to 0.006) −0.002 (−0.005 to 0.002) 0 (ref.) 0.001 (−0.003 to 0.005) 0.005 (−0.006 to 0.016)
Numbers show lung function parameter relative to value at the median AChE/Hb in the analysis, with 95% CI.
Absolute lung function measures: All analyses (including unadjusted) include sex, age and height as covariates. Basic covariate set=age, sex, height, pack- years of smoking, cumulated lifetime 
hours of cooking. Extended covariate set=basic set+BMI, years of full- time education.
Z- scores: Basic covariate set = age, sex, pack- years of smoking, cumulated lifetime hours of cooking. Extended covariate set=basic set+BMI, years of full- time education.
AChE/Hb, erythrocyte acetylcholinesterase normalised by haemoglobin concentration; BMI, body mass index.
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human trial on the pulmonary effects of the cholinesterase inhib-
itor medicine pyridostigmine in healthy volunteers. After admin-
istration of 60 mg of pyridostigmine, FEV1 decreased on average 
130 mL, strongly correlated with the degree of acetylcholin-
esterase inhibition that ranged from ~20% to ~40%.36 In the 
present study, median AChE/Hb was 26.3 U/g at baseline. While 
AChE/Hb has a wide normal range,17 26.3 U/g is only 84% of 
the reference value (31.4 U/g) stated by the manufacturer of the 
device that we used to measure AChE/Hb.17 Hence, the degrees 
of cholinesterase inhibition in our study population and in the 
previous experimental study are of the same order of magnitude.
The effect sizes demonstrated in the study were modest, but 
non- negligible. In the analysis of the influence of AChE/Hb on 
the absolute value of FEV1, there was an estimated difference of 
78 (9 to 148) mL in FEV1 between the 5
th and 95th percentiles 
of AChE/Hb, after adjustment for the basic set of confounders. 
While this is below the Minimal Clinically Important Differ-
ence in FEV1 of 100 mL in pharmacological trials,
37 it is a rele-
vant difference at population level. In comparison, a systematic 
review on the pulmonary effects of outdoor air pollution found 
that each 10 µg/m3 increase in short- term exposure to PM2.5 was 
associated with a −7.02 (−11.75 to –2.29) mL change in FEV1.
38
The strength of this study is the relatively large study popu-
lation, all recruited from farmers’ organisations, and followed 
over time to account for both interindividual and intraindividual 
variability in pesticide exposure. We had low losses to follow- up. 
Exposure and outcome were objectively determined following 
established standards, and we accounted for confounders defined 
a priori based on Directed Acyclic Graphs.21
Our study also has clear limitations. Foremost, our sampling 
strategy was convenience- based, that is, participants were 
recruited from farmers’ organisations that we presumed a priori 
to have different mean exposure levels, but similar demographics. 
Limited information from each recruitment meeting was avail-
able regarding the number and characteristics of farmers who 
did not wish to participate in our study, and selection bias before 
baseline is theoretically possible. The proportion of female 
participants was high (69%), but this does not necessarily reflect 
imbalanced selection by sex, as the overall proportion of women 
among individuals economically active in agriculture in Uganda 
is 50%,39 and 56% of the labour time in Ugandan agriculture 
is provided by women.40 Loss to follow- up between phases 
was negligible and unlikely to introduce any considerable bias. 
However, some selection bias could have been introduced by 
(un)availability of spirometry data for included participants. We 
conducted a post- hoc analysis limited to spirometric results from 
phase 1, as Directed Acyclic Graphs showed that in this phase, 
the potential for selection bias was lower than in the study overall 
(see figure 2 and online supplemental appendix 2). The associa-
tion between low AChE/Hb and low FEV1 Z- score disappeared 
in this cross- sectional analysis (online supplemental appendix 2). 
This could indicate that our main analyses are biassed by selec-
tion processes, but on the other hand, the cross- sectional analysis 
did not account for the considerable physiological variation in 
AChE/Hb.17
Pulmonary function was only assessed by pre- bronchodilator 
spirometry, as we did not have ethical clearance to administer 
bronchodilator medicine to participants. Hence, we cannot tell 
if airway obstruction was reversible.
We could confirm relationships between spirometric results 
and well- known determinants of pulmonary function, for 
example, age, sex and height (online supplemental appendix 
2), strengthening our confidence in results related to AChE/
Hb. Unexpectedly, we found no consistent associations between 
biomass smoke exposure or tobacco consumption with pulmo-
nary function. The latter is probably due to power issues, as few 
Figure 4 Results from fixed effect model of change in pulmonary function and AChE/Hb from phase 1 to phase 3. Solid line shows lung function 
parameter relative to value at the median Δ(AChE/Hb). Dashed lines show 95% CI. Spline knot location shown by black dots. Histograms show 
the distribution of Δ(AChE/Hb) values for observations in the model. Basic covariate set=Δage, Δpack- years, Δ(hours of cooking in the last week). 
Extended covariate set=basic set+ΔBMI. AChE/Hb,erythrocyte acetylcholinesterase normalised by haemoglobin concentration.
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of the participants had ever smoked, and our metric for biomass 
smoke was crude, meaning there is likely bias toward the null. 
Residual confounding due to the crude exposure metric for 
biomass smoke is likely limited, as biomass exposure is prob-
ably determined by a combination of sex, age and socioeconomic 
status—variables that we have adjusted for.
The median Z- scores for FEV1, FVC and FEF25-75 in the study 
population were <0 in all phases, while the Z- score for FEV1/
FVC was >0. This could be a result of the harmful influence 
of various exposures on pulmonary function, or because the 
GLI-2012 equations16 do not include data from Uganda. Due 
to a lack of normal values for the Ugandan population, we used 
normal values for African- Americans. We analysed the Z- scores 
as continuous variables, and adjusted analyses of the raw metrics 
FEV1, FVC, FEV1/FVC and FEF25-75 gave similar results to the 
analyses based on the corresponding Z- scores. Therefore, the 
use of African- Americans as reference population is unlikely to 
pose a threat to the internal validity of our findings.
A considerable number of statistical analyses were conducted. 
Nevertheless, we do not think that multiple comparisons pose a 
substantial problem for the study validity, as we decided a priori 
which covariates to adjust for, which outcomes were primary 
and secondary, and which analyses were primary, secondary and 
sensitivity analyses. Furthermore, we see clear and consistent 
patterns for each exposure–outcome pair in the random coeffi-
cient models. We prepublished the analysis protocol in an online 
repository,21 and all deviations from protocol are listed in online 
supplemental appendix 2.
While we believe that our findings are generalisable to small-
holder farmers using organophosphate and carbamate insecti-
cides in Eastern Africa, care should be taken before extrapolating 
the findings to other populations with lower exposure levels, for 
example, farmers applying pesticides in high- income countries 
or consumers eating fruits and vegetables with pesticide residues. 
The PEXADU project population has a relatively high exposure 
to pesticides due to a lack of training on proper handling of 
pesticides and poor use of personal protective equipment.14 
Further studies are needed to investigate whether similar effects 
can be demonstrated in lower- exposed populations.
CONCLUSION
Our main analyses indicate that occupational exposure to 
organophosphate and carbamate insecticides may lead to lung 
function impairment, though diverging results from some sensi-
tivity and secondary analyses mean that caution is warranted 
when interpreting the findings. Nevertheless, our results add to 
the growing evidence of health effects in relation to exposure 
to organophosphate and carbamate insecticides, underlining 
the importance of preventive measures to avoid or minimise 
exposure.
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